BIOTRON *

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2002-07-02 for BIOTRON * manufactured by Biotron.

Event Text Entries

[277681] Event date approximation of date pt began seeing a nurse using galvanic skin response measurement device mfg by biotron. She claimed to be able to detect both the presence and absence of cancer cells in various organs and the lymphatic system with this machine. Pt was diagnosed with melanoma. They declined "traditional" treatment with hosp and was monitored and treated by nurse with previously mentioned device. When this nurse first saw pt, she told pt they were cancer-free. She indicated to rptr that she had detected cancer cells several times during the 2-year period of visits, however, she "got rid of them". Saw her approx 9 hrs prior to their death. She stated then that she could not detect the presence of cancer cells in pt's body, only arsenic.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report NumberMW1025561
MDR Report Key404756
Date Received2002-07-03
Date of Report2002-07-02
Date of Event2000-08-01
Date Added to Maude2002-07-16
Event Key0
Report Source CodeVoluntary report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Reporter OccupationPATIENT FAMILY MEMBER OR FRIEND
Health Professional3
Initial Report to FDA0
Report to FDA0
Event Location3
Single Use0
Previous Use Code0
Event Type3
Type of Report3

Device Details

Brand NameBIOTRON
Generic NameGALVANIC SKIN RESPONSE MEASUREMENT DEVICE
Product CodeGZO
Date Received2002-07-02
Model Number*
Catalog Number*
Lot Number*
ID Number*
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Implant FlagN
Date Removed*
Device Sequence No1
Device Event Key393753
ManufacturerBIOTRON
Manufacturer AddressUNK UNK *


Patients

Patient NumberTreatmentOutcomeDate
101. Death 2002-07-03

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.